Clinical Trials Directory

Trials / Conditions / Diabetic Macular Oedema

Diabetic Macular Oedema

17 registered clinical trials studyying Diabetic Macular Oedema1 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study to Evaluate the Efficacy and Safety of IBI302 inSubjects With Diabetic Macular Edema(DME)
NCT06908876
Innovent Biologics Technology Limited (Shanghai R&D Center)Phase 2
CompletedSafety and Efficacy of IBE-814 Intravitreal (IVT) Implant - a Sustained, Low Dose Dexamethasone Therapy
NCT04576689
Ripple Therapeutics Pty LtdPhase 2
CompletedStudy of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX Study
NCT02731911
Allergan
CompletedNear Infrared Photobiomodulation Treatment for Diabetic Macular Oedema
NCT02181400
University of SydneyN/A
TerminatedThe Use of ARA290 for the Treatment of Diabetic Macular Oedema
NCT06626971
Belfast Health and Social Care TrustPhase 2
CompletedAflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa
NCT02554747
Odense University HospitalN/A
CompletedEffectiveness of Training in Reading Rehabilitation for Patients With Diabetic Macular Oedema
NCT02457884
The Hong Kong Polytechnic UniversityN/A
TerminatedNoctura400 Treatment for Diabetic Retinopathy (CANDLE)
NCT02207712
PolyPhotonix MedicalN/A
CompletedTrial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Pers
NCT01787669
University of SydneyPhase 2
WithdrawnSub-threshold Photocoagulation of Diabetic Macular Oedema
NCT02309476
Manchester University NHS Foundation TrustN/A
CompletedTo Evaluate the Comparative Efficacy of Lucentis (Ranibizumab) 0.5mg Intravitreal Injection in Patients With D
NCT03495765
Marsden Eye SpecialistsPhase 3
CompletedIntravitreal Macugen for Ischaemic Diabetic Macular Oedema
NCT01175070
University of OxfordPhase 4
TerminatedClinical Study of the Effect of Intravenous Galactose on Diabetic Macular Oedema
NCT00427986
Glostrup University Hospital, CopenhagenN/A
CompletedOpen Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study
NCT00148330
University of SydneyPhase 2 / Phase 3
CompletedA Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macula
NCT00148265
University of SydneyPhase 2 / Phase 3
CompletedQuantification of Rising the Osmotic Pressure in Diabetic Intraretinal Fluid Accumulation (Diabetic Macular Oe
NCT00333671
Glostrup University Hospital, CopenhagenN/A
CompletedIntravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatm
NCT00167518
University of SydneyPhase 2 / Phase 3